LIFECORE BIOMEDICAL, INC. \DE\
Price data unavailable
Track LFCR in your trading journalAbout LIFECORE BIOMEDICAL, INC. \DE\
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) is a US-listed equity tracked across major market indices. Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
The company reports trailing twelve-month revenue of $152.78M and net loss of $14.98M. Key metrics include a return on equity of 52.7%, a debt-to-equity ratio of -7.20.
FINOTAUR provides free research summaries, news aggregation, and fundamentals for LFCR to support both active traders and long-term investors.
Fundamentals
| Revenue (TTM) | $152.78M |
| Net Income (TTM) | $-14.98M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 52.68% |
| Debt-to-Equity | -7.20 |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·Apr 6
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCR
- GlobeNewswire Inc.·Mar 23
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
- GlobeNewswire Inc.·Mar 17
Green Dot Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Want real-time analysis on LFCR?
Track it free in your trading journal. Log trades, tag setups, and review your edge.